AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates

By Yahoo! Finance | Nov 7, 2024 at 07:59 AM EST

AbCellera Biologics Inc. disappointed analysts with lower-than-expected quarterly results. Analysts have revised forecasts, predicting a 37% revenue increase in 2025. Despite concerns, price targets vary widely, suggesting uncertainty about the company's future growth potential compared to industry averages.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.